U.S. Healthcare Services Stock News

The United States market has shown impressive strength, rising 3.5% over the last week and climbing 31% over the past year, with earnings projected to grow by 16% annually. In such a robust environment, identifying lesser-known stocks with strong fundamentals and growth potential can offer intriguing opportunities for investors seeking to diversify their portfolios.

Porch Group, Inc. ( NASDAQ:PRCH ) is possibly approaching a major achievement in its business, so we would like to...

Readers hoping to buy Accenture plc ( NYSE:ACN ) for its dividend will need to make their move shortly, as the stock is...

The United States market has experienced a notable upswing, rising 3.5% over the past week and an impressive 31% over the last year, with earnings projected to grow by 16% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies that not only capitalize on current technological trends but also demonstrate strong potential for sustained revenue expansion and innovation.

The United States market has shown a robust performance, rising 3.5% over the last week and 31% over the past year, with earnings projected to grow by 16% annually. In such a thriving environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

The United States market has experienced a robust performance, rising 3.5% over the last week and climbing 31% over the past year, with earnings projected to grow by 16% annually. In this thriving environment, identifying promising small-cap stocks can be key to unlocking potential opportunities that may not yet be fully recognized by the broader market.

Despite the fact that Lightbridge Corporation (NASDAQ:LTBR) stock rose 13% last week, insiders who sold US$832k worth...

CEVA, Inc. ( NASDAQ:CEVA ), might not be a large cap stock, but it saw a decent share price growth of 14% on the...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

The Morning Bull - US Market Morning Update Monday, Apr, 6 2026 US stock futures are pointing higher this morning, with E mini S&P 500 contracts up about 0.7% and Nasdaq 100 futures up just over 1%, as investors weigh a mix of strong jobs data and signs of cooling inflation. Nonfarm payrolls rose by 178,000 in March while unemployment sits at 4.3% and wage growth is 3.5% year on year, suggesting more people are working but pay pressures are easing. At the same time, the US Services PMI has...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

We can readily understand why investors are attracted to unprofitable companies. Indeed, vTv Therapeutics ( NASDAQ:VTVT...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

CSG Systems International (NasdaqGS:CSGS) has entered a significant partnership with ePLDT Group to support digital solutions and enterprise services in the Philippines. The collaboration extends CSG’s platform solutions into a new Southeast Asian market within the region’s information and communications technology sector. The agreement focuses on helping enterprise clients streamline and manage their digital offerings across a growing set of services. CSG Systems International, known for...

Context for recent stock performance With no single headline event driving attention to JBG SMITH Properties (JBGS), the focus for investors has centered on its recent share performance and operating profile in Washington, DC centered mixed-use real estate. See our latest analysis for JBG SMITH Properties. The recent 1 day share price return of 0.83% decline and 90 day share price return of 14.65% decline signal fading short term momentum. At the same time, the 3 year total shareholder return...

Why Hologic (HOLX) is on investors’ radar today Hologic (HOLX) has drawn investor interest recently as its share price, which last closed at US$75.65, reflects mixed short term performance and a moderate gain over the past 3 months. Over the past month, Hologic’s return was roughly flat, while the past 3 months show a gain of about 1%. Over the past year, the stock’s total return of about 24% contrasts with a slight negative total return over 3 years and a modest gain over 5 years. These...

Recently, activist investor Land & Buildings raised its stake in Centerspace REIT to 9.19%, coinciding with Board Member Emily Nagle Green’s retirement and the declaration of a quarterly dividend. Taken together, the larger activist presence and board change may point to upcoming discussions around Centerspace’s capital allocation and portfolio direction. With Land & Buildings now owning over 9% of Centerspace, we’ll examine how this increased activist involvement could reshape its...

FuboTV (NYSE:FUBO) approved a reverse stock split and amended its bylaws to reflect the change. The reverse split has already been implemented, consolidating existing shares into a smaller number. These actions adjust the company’s share structure and may influence its exchange listing status and future financing options. FuboTV operates a live TV streaming platform focused on sports, news, and entertainment, positioning itself as an alternative to traditional cable bundles. The reverse...

Why Sealed Air Is On Investors’ Radar Sealed Air (SEE) has been drawing attention after recent share price moves, prompting investors to take a fresh look at its packaging business, current valuation signals, and how its returns have varied across different time frames. See our latest analysis for Sealed Air. The share price at US$42.08 has been relatively steady in the short term, while the 1 year total shareholder return of 76.16% contrasts with flat to slightly negative total shareholder...

RCM Technologies (RCMT) has wrapped up FY 2025 with fourth quarter revenue of US$86.5 million, basic EPS of US$0.80 and net income of US$6.1 million. The trailing twelve months show revenue of US$319.4 million, EPS of US$2.19 and net income of US$16.3 million, with earnings growth of 22.4% over the past year. Over recent periods the company has seen revenue move from US$278.4 million to US$319.4 million on a trailing basis, alongside EPS shifting from US$1.72 to US$2.19. This ties into a net...

In recent months, Soleno Therapeutics has faced multiple securities class action lawsuits alleging that the company and certain executives failed to disclose material safety concerns and data integrity issues tied to the Phase 3 program for its Prader‑Willi syndrome drug DCCR, marketed as VYKAT XR. These legal challenges, centered on claims of undisclosed risks such as fluid retention, diabetes‑related markers, and high discontinuation rates, have intensified scrutiny of VYKAT XR’s clinical...

AI data centers, stubborn energy costs, and heightened geopolitical risk are all pushing reliable, carbon free power to the forefront of investment thinking. Nuclear sits at the center of that discussion, with governments, utilities, and large corporates all searching for 24/7 electricity that does not depend on weather or imported fossil fuels. Our Nuclear Renaissance screener is built to help you focus on listed companies most closely aligned with this long term trend. In this article, you...

For investors wondering if Turning Point Brands at around US$72.16 is still offering value or if the easy gains are behind it, this article focuses squarely on what the current price might be implying. The stock has pulled back sharply in the short term, with a 15.5% decline over the last 7 days and a 21.9% decline over the last 30 days, even though the 1 year return sits at 32.8% and the 3 year return is 254.2%. Recent market attention has centered on how this performance, including a year...

Royalty Pharma (NasdaqGS:RPRX) has entered into a new R&D co-funding agreement with Johnson & Johnson to develop a novel autoimmune therapy. The company has also appointed a Head of Artificial Intelligence to expand the use of advanced analytics and data science across its operations. These announcements mark a shift toward greater involvement in drug development and data driven decision making. Royalty Pharma, known primarily for acquiring biopharma royalties, typically gives investors...